Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations

[1]  M. McMahon,et al.  AKT1 Activation Promotes Development of Melanoma Metastases. , 2015, Cell reports.

[2]  D. Stumpo,et al.  Myristoylated Alanine‐Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation , 2015, Journal of the American Heart Association.

[3]  P. Timpson,et al.  The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis. , 2015, Cancer cell.

[4]  Ji Luo,et al.  LAMC2 enhances the metastatic potential of lung adenocarcinoma , 2015, Cell Death and Differentiation.

[5]  Huei-Wen Chen,et al.  Snail regulates Nanog status during the epithelial–mesenchymal transition via the Smad1/Akt/GSK3β signaling pathway in non-small-cell lung cancer , 2014, Oncotarget.

[6]  M. Socinski,et al.  Phase II study of the AKT inhibitor MK-2206 plus erlotinib (E) in patients (pts) with advanced non-small cell lung cancer (NSCLC) who progressed on prior erlotinib: A California Cancer Consortium Phase II trial (NCI 8698). , 2014 .

[7]  J. Tabernero,et al.  Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors , 2014, Molecular Cancer Therapeutics.

[8]  Ya-hong Zhang,et al.  Distinct roles of Akt1 in regulating proliferation, migration and invasion in HepG2 and HCT 116 cells. , 2014, Oncology reports.

[9]  Emanuel F Petricoin,et al.  Preparation and Use of Reverse Protein Microarrays , 2014, Current protocols in protein science.

[10]  C. Rommel,et al.  PI3K and cancer: lessons, challenges and opportunities , 2014, Nature Reviews Drug Discovery.

[11]  J. Rodríguez-Ubreva,et al.  Distinct and specific roles of AKT1 and AKT2 in androgen-sensitive and androgen-independent prostate cancer cells. , 2013, Cellular signalling.

[12]  Adam T. Melvin,et al.  Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein , 2013, PloS one.

[13]  V. Carloni,et al.  Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. , 2013, Cancer letters.

[14]  B. Hemmings,et al.  PKB/Akt-dependent regulation of cell motility. , 2013, Journal of the National Cancer Institute.

[15]  J. Rantala,et al.  Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer , 2012, Molecular biology of the cell.

[16]  J. Rantala,et al.  451 Distinct Roles of AKT Isoforms in Regulating Beta1-integrin Activity, Migration and Invasion in Prostate Cancer , 2012 .

[17]  K. Pantel,et al.  Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. , 2011, Cellular signalling.

[18]  N. Girard,et al.  New driver mutations in non-small-cell lung cancer. , 2011, The Lancet. Oncology.

[19]  Sarat Chandarlapaty,et al.  AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. , 2011, Cancer cell.

[20]  R. Figlin,et al.  Akt inhibitors in clinical development for the treatment of cancer , 2010, Expert opinion on investigational drugs.

[21]  P. Majumder,et al.  MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo , 2010, Molecular Cancer Therapeutics.

[22]  L. Stewart,et al.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data , 2010, The Lancet.

[23]  M. Moran,et al.  Epidermal growth factor receptor variant III-induced glioma invasion is mediated through myristoylated alanine-rich protein kinase C substrate overexpression. , 2009, Cancer research.

[24]  J. Zha,et al.  Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis , 2009, Oncogene.

[25]  Jeffrey A. Engelman,et al.  Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.

[26]  A. Toker,et al.  FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases , 2009, Molecular and Cellular Biology.

[27]  G. Mills,et al.  Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. , 2009, Cancer research.

[28]  M. Meyerson,et al.  PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. , 2009, Cancer research.

[29]  A. Toker,et al.  Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. , 2009, Cellular signalling.

[30]  S. Sheng,et al.  Metastasis and AKT activation , 2008, Cell cycle.

[31]  S. Lippman,et al.  Lung cancer. , 2008, The New England journal of medicine.

[32]  E. Lam,et al.  The emerging roles of forkhead box (Fox) proteins in cancer , 2007, Nature Reviews Cancer.

[33]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[34]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[35]  M. Birnbaum,et al.  Opposing Roles for Akt1 and Akt2 in Rac/Pak Signaling and Cell Migration* , 2006, Journal of Biological Chemistry.

[36]  P. Jänne,et al.  Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. , 2006, The Journal of clinical investigation.

[37]  Hong Liu,et al.  Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Brugge,et al.  Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition , 2005, The Journal of cell biology.

[39]  Y. Chu,et al.  Expression of axl in lung adenocarcinoma and correlation with tumor progression. , 2005, Neoplasia.

[40]  A. Toker,et al.  Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. , 2005, Molecular cell.

[41]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[42]  Y. Murakumo,et al.  Akt/PKB regulates actin organization and cell motility via Girdin/APE. , 2005, Developmental cell.

[43]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[44]  K. Hunter,et al.  Modeling metastasis in vivo. , 2004, Carcinogenesis.

[45]  Robert D Cardiff,et al.  Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. , 2004, Cancer research.

[46]  S. Dedieu,et al.  Myoblast migration is prevented by a calpain‐dependent accumulation of MARCKS , 2003, Biology of the cell.

[47]  William C Reinhold,et al.  Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Brian A. Hemmings,et al.  Protein Kinase Bα/Akt1 Regulates Placental Development and Fetal Growth* , 2003, Journal of Biological Chemistry.

[49]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[50]  Emanuel F Petricoin,et al.  Protein microarrays: meeting analytical challenges for clinical applications. , 2003, Cancer cell.

[51]  R. Glazer,et al.  Akt1 induces extracellular matrix invasion and matrix metalloproteinase-2 activity in mouse mammary epithelial cells. , 2001, Cancer research.

[52]  H. Koh,et al.  Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  Kim Dohoon,et al.  Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production , 2001 .

[54]  T. Kallunki,et al.  Laminin-5 promotes adhesion and migration of epithelial cells: identification of a migration-related element in the gamma2 chain gene (LAMC2) with activity in transgenic mice. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[55]  P. Janmey,et al.  MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium–calmodulin , 1992, Nature.

[56]  E. Petricoin,et al.  Reverse Phase Protein Microarrays. , 2017, Methods in molecular biology.

[57]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[58]  J. Koo,et al.  EGFR and HER-2 status of non-small cell lung cancer brain metastasis and corresponding primary tumor. , 2011, Neoplasma.

[59]  S. Naber,et al.  Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. , 2007, Cancer research.

[60]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.